Trilostane for Androgen-Independent Prostate Cancer
Completed
Genzyme, a Sanofi Company
Phase 2
2004-03-01
The main purpose of this study is to test the safety of trilostane by looking at what
effects, good and bad, it has on patients with androgen-independent prostate cancer.
Randomized Study of Letrozole and Trilostane for Medical Abortion
Terminated
Karolinska Institutet
Phase 2
2012-05-01
In menstruation an effective shedding of the endometrial lining occurs. Both progesterone and
estrogen levels fall sharply at this time. During medical abortion the endometrial shedding
is sometimes ineffective causing an incomplete abortion which may cause prolonged bleeding or
require surgical intervention. In medical abortion a progesterone antagonist is used as
treatment but the estrogen levels are not targeted. The investigators wish to explore whether
addition of letrozole or trilostane which target estrogen levels can lead to a more effective
shedding of the endometrial lining.
Randomized Study of Letrozole and Trilostane for Medical Abortion
Terminated
The University of Hong Kong
Phase 2
2012-05-01
In menstruation an effective shedding of the endometrial lining occurs. Both progesterone and
estrogen levels fall sharply at this time. During medical abortion the endometrial shedding
is sometimes ineffective causing an incomplete abortion which may cause prolonged bleeding or
require surgical intervention. In medical abortion a progesterone antagonist is used as
treatment but the estrogen levels are not targeted. The investigators wish to explore whether
addition of letrozole or trilostane which target estrogen levels can lead to a more effective
shedding of the endometrial lining.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
